IL149098A0 - Positive modulators of nicotinic receptor agonists - Google Patents
Positive modulators of nicotinic receptor agonistsInfo
- Publication number
- IL149098A0 IL149098A0 IL14909800A IL14909800A IL149098A0 IL 149098 A0 IL149098 A0 IL 149098A0 IL 14909800 A IL14909800 A IL 14909800A IL 14909800 A IL14909800 A IL 14909800A IL 149098 A0 IL149098 A0 IL 149098A0
- Authority
- IL
- Israel
- Prior art keywords
- receptor agonists
- nicotinic receptor
- positive modulators
- modulators
- positive
- Prior art date
Links
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 title 1
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 title 1
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9903997A SE9903997D0 (sv) | 1999-11-03 | 1999-11-03 | New compounds |
| PCT/SE2000/002148 WO2001032619A1 (en) | 1999-11-03 | 2000-11-01 | Positive modulators of nicotinic receptor agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL149098A0 true IL149098A0 (en) | 2002-11-10 |
Family
ID=20417607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14909800A IL149098A0 (en) | 1999-11-03 | 2000-11-01 | Positive modulators of nicotinic receptor agonists |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6750242B1 (enExample) |
| EP (1) | EP1230216A1 (enExample) |
| JP (1) | JP2003513071A (enExample) |
| KR (1) | KR20020063176A (enExample) |
| CN (1) | CN1239482C (enExample) |
| AU (1) | AU783507B2 (enExample) |
| BR (1) | BR0015195A (enExample) |
| CA (1) | CA2387745A1 (enExample) |
| CO (1) | CO5251458A1 (enExample) |
| IL (1) | IL149098A0 (enExample) |
| MX (1) | MXPA02004232A (enExample) |
| NO (1) | NO323076B1 (enExample) |
| NZ (2) | NZ518450A (enExample) |
| SE (1) | SE9903997D0 (enExample) |
| WO (1) | WO2001032619A1 (enExample) |
| ZA (1) | ZA200203171B (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9903998D0 (sv) * | 1999-11-03 | 1999-11-03 | Astra Ab | New compounds |
| DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
| DE10234424A1 (de) * | 2002-07-29 | 2004-02-12 | Bayer Ag | Benzothiophen-, Benzofuran- und Indolharnstoffe |
| JP2006501246A (ja) | 2002-08-30 | 2006-01-12 | メモリー・ファーマシューティカルズ・コーポレイション | 神経変性疾患の治療において有用なアナバセイン誘導体 |
| AU2003276919B2 (en) | 2002-09-25 | 2013-05-16 | Memory Pharmaceuticals Corporation | Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof |
| US20050234095A1 (en) | 2004-03-25 | 2005-10-20 | Wenge Xie | Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof |
| CN101247853B (zh) * | 2005-04-13 | 2014-11-12 | 轴突公司 | 具有nos抑制活性的取代的吲哚化合物 |
| US20070134169A1 (en) * | 2005-12-11 | 2007-06-14 | Rabinoff Michael D | Methods for smoking cessation or alcohol cessation or other addiction cessation |
| US7989447B2 (en) | 2006-04-13 | 2011-08-02 | Neuraxon, Inc. | 1,5 and 3,6-substituted indole compounds having NOS inhibitory activity |
| AU2008321353A1 (en) * | 2007-11-16 | 2009-05-22 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods for treating visceral pain |
| MX2010005343A (es) * | 2007-11-16 | 2010-08-09 | Neuraxon Inc | Compuestos indola 3, 5-sustituidos que tienen actividad inhibidora de la re-absorcion y el reciclo de nos y norepinefrina. |
| JP2011503120A (ja) * | 2007-11-16 | 2011-01-27 | ニューラクソン，インコーポレーテッド | 内臓痛を治療するためのインドール化合物および方法 |
| US8383657B2 (en) | 2007-12-21 | 2013-02-26 | Abbott Laboratories | Thiazolylidine urea and amide derivatives and methods of use thereof |
| AU2009212259A1 (en) * | 2008-02-07 | 2009-08-13 | Abbott Laboratories | Amide derivatives as positive allosteric modulators and methods of use thereof |
| UY31769A1 (es) | 2008-04-17 | 2009-09-30 | Derivados del indol con actividad modulatoria del receptor nicotínico de acetilcolina | |
| JP5642154B2 (ja) * | 2009-04-16 | 2014-12-17 | プロキシマジェン エルティーディーＰｒｏｘｉｍａｇｅｎ Ｌｔｄ． | α７ｎＡＣｈＲのインドール誘導体モジュレータ |
| JP5749797B2 (ja) * | 2010-05-17 | 2015-07-15 | フォルム ファーマシューティカルズ、インコーポレイテッド | （ｒ）−７−クロロ−ｎ−（キヌクリジン−３−イル）ベンゾ［ｂ］チオフェン−２−カルボキサミド塩酸塩一水和物の結晶形 |
| TW201245185A (en) | 2011-04-01 | 2012-11-16 | Lundbeck & Co As H | New positive allosteric modulators of nicotinic acetylcholine receptor |
| AR086791A1 (es) | 2011-07-01 | 2014-01-22 | Lundbeck & Co As H | Moduladores alostericos positivos del receptor de acetilcolina nicotinico |
| CA2872005A1 (en) | 2012-05-08 | 2013-11-14 | Forum Pharmaceuticals, Inc. | Methods of maintaining, treating or improving cognitive function |
| WO2020045982A1 (ko) * | 2018-08-29 | 2020-03-05 | 숙명여자대학교산학협력단 | 치환된 인돌 유도체, 이의 제조방법 및 이를 유효성분으로 포함하는 PPARα, PPARγ 및 PPARδ 관련 질환의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2787551A (en) * | 1954-02-24 | 1957-04-02 | Eastman Kodak Co | Compositions stabilized with hydroxyindole |
| BE758766A (fr) * | 1969-11-17 | 1971-05-10 | Ici Ltd | Nouveaux derives de la morpholine et de la |
| US4704390A (en) * | 1986-02-13 | 1987-11-03 | Warner-Lambert Company | Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents |
| KR930702334A (ko) * | 1990-09-13 | 1993-09-08 | 데이비드 로버트 | 5 하이드록시트립타민 수용체 길항제로서의 인돌우레아 |
| RU2126399C1 (ru) * | 1991-11-25 | 1999-02-20 | Пфайзер Инк. | Производные индола, замещенные индолы и способ ингибирования 5ht1 рецептора серотонина |
| WO1993018026A1 (en) * | 1992-03-04 | 1993-09-16 | Beecham Group Plc | Indole ureas as 5-ht1c receptor antogonists |
| US5504101A (en) * | 1994-05-06 | 1996-04-02 | Allelix Biopharmaceuticals, Inc. | 5-HT-1D receptor ligands |
| FR2722686B1 (fr) * | 1994-07-22 | 1996-08-30 | Oreal | Set, procede, dispositif et composition de teinture des fibres keratiniques |
| US5576321A (en) * | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
-
1999
- 1999-11-03 SE SE9903997A patent/SE9903997D0/xx unknown
-
2000
- 2000-11-01 CA CA002387745A patent/CA2387745A1/en not_active Abandoned
- 2000-11-01 EP EP00976500A patent/EP1230216A1/en not_active Withdrawn
- 2000-11-01 IL IL14909800A patent/IL149098A0/xx unknown
- 2000-11-01 KR KR1020027005706A patent/KR20020063176A/ko not_active Ceased
- 2000-11-01 NZ NZ518450A patent/NZ518450A/en unknown
- 2000-11-01 MX MXPA02004232A patent/MXPA02004232A/es unknown
- 2000-11-01 CN CNB008154414A patent/CN1239482C/zh not_active Expired - Fee Related
- 2000-11-01 BR BR0015195-5A patent/BR0015195A/pt not_active IP Right Cessation
- 2000-11-01 JP JP2001534771A patent/JP2003513071A/ja not_active Abandoned
- 2000-11-01 US US10/111,027 patent/US6750242B1/en not_active Expired - Fee Related
- 2000-11-01 AU AU14264/01A patent/AU783507B2/en not_active Ceased
- 2000-11-01 WO PCT/SE2000/002148 patent/WO2001032619A1/en not_active Ceased
- 2000-11-01 NZ NZ530161A patent/NZ530161A/en unknown
- 2000-11-01 CO CO00083175A patent/CO5251458A1/es not_active Application Discontinuation
-
2002
- 2002-04-22 ZA ZA200203171A patent/ZA200203171B/xx unknown
- 2002-04-26 NO NO20022009A patent/NO323076B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR0015195A (pt) | 2002-06-18 |
| ZA200203171B (en) | 2003-09-23 |
| CN1239482C (zh) | 2006-02-01 |
| WO2001032619A1 (en) | 2001-05-10 |
| NO323076B1 (no) | 2006-12-27 |
| CO5251458A1 (es) | 2003-02-28 |
| MXPA02004232A (es) | 2002-10-17 |
| AU783507B2 (en) | 2005-11-03 |
| NO20022009D0 (no) | 2002-04-26 |
| AU1426401A (en) | 2001-05-14 |
| KR20020063176A (ko) | 2002-08-01 |
| US6750242B1 (en) | 2004-06-15 |
| NZ530161A (en) | 2005-08-26 |
| NZ518450A (en) | 2004-04-30 |
| CN1387512A (zh) | 2002-12-25 |
| EP1230216A1 (en) | 2002-08-14 |
| CA2387745A1 (en) | 2001-05-10 |
| NO20022009L (no) | 2002-07-02 |
| JP2003513071A (ja) | 2003-04-08 |
| SE9903997D0 (sv) | 1999-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL149096A0 (en) | Positive modulators of nicotinic receptor agonists | |
| IL149098A0 (en) | Positive modulators of nicotinic receptor agonists | |
| EG25606A (en) | Glucocorticoid receptor modulators | |
| AU5203999A (en) | Beta3-adrenergic receptor agonists | |
| AU1293101A (en) | Ep4 receptor selective agonists in the treatment of osteoporosis | |
| AU2056800A (en) | Heterocyclic piperidines as modulators of chemokine receptor activity | |
| PL342843A1 (en) | Novel compounds and their use as positive ampa receptor modulators | |
| AP2001002269A0 (en) | Chemokine receptor binding heterocyclic compounds | |
| HUP0200429A2 (en) | Soluble receptor br43x2 and methods of using | |
| EP1140086A4 (en) | N-UREIDOALKYL-PIPERIDINES FOR USE AS MODULATORS OF THE ACTIVITY OF CHIMIOKIN RECEPTORS | |
| EG23980A (en) | Potassium salt of (s)-omeprazole | |
| IL144289A0 (en) | Functionalized heterocycles as chemokine receptor modulators | |
| AU5095000A (en) | Receptor interacting protein rip3 | |
| AU2441801A (en) | Urotensin-ii receptor antagonists | |
| IL146151A0 (en) | Human-g-protein receptor | |
| IL148266A0 (en) | Apo-2 receptor antibodies | |
| AU1745501A (en) | Positive modulators of nicotinic receptor agonists | |
| AU5861900A (en) | Receptor agonists and antagonists | |
| PL348504A1 (en) | Substituted heterocyclic acyl-tripeptides useful as thrombin receptor modulators | |
| IL146280A0 (en) | Cyclocarbamate derivatives as progesterone receptor modulators | |
| GB9908311D0 (en) | Cable joint holder | |
| NZ513586A (en) | Small molecule modulators of G protein-coupled receptor six | |
| AU6514400A (en) | Method of identifying urotensin ii receptor antagonists | |
| AU2512800A (en) | Alpha1-adrenergic receptor antagonists | |
| GB9922009D0 (en) | CCR5 Modulators |